Aytu Biopharma, Inc SEC filings AYTU

Aytu Biopharma, Inc has 907 filings in SEC EDGAR's recent list, going back to Jan 11, 2007. Its latest annual report, Form 10-K, was filed on Sep 22, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (results of operations). The company's fiscal year ends on June 30.

Aytu Biopharma, Inc SEC filings
Form Description Filed Period
10-Q Quarterly report May 13, 2026 Mar 31, 2026
10-Q Quarterly report Feb 3, 2026 Dec 31, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
10-Q Quarterly report Feb 12, 2025 Dec 31, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
10-Q Quarterly report Feb 21, 2023 Dec 31, 2022
10-Q/A Amended quarterly report Feb 21, 2023 Sep 30, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
10-Q Quarterly report Feb 11, 2021 Dec 31, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
10-Q Quarterly report Feb 14, 2020 Dec 31, 2019
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
10-Q Quarterly report May 14, 2019 Mar 31, 2019
10-Q/A Amended quarterly report May 14, 2019 Dec 31, 2018
10-Q Quarterly report Feb 7, 2019 Dec 31, 2018
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
10-Q Quarterly report May 14, 2018 Mar 31, 2018
10-Q Quarterly report Feb 8, 2018 Dec 31, 2017
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
10-Q Quarterly report May 11, 2017 Mar 31, 2017
10-Q Quarterly report Feb 9, 2017 Dec 31, 2016
10-Q Quarterly report Nov 7, 2016 Sep 30, 2016
10-Q Quarterly report May 11, 2016 Mar 31, 2016
10-Q Quarterly report Feb 11, 2016 Dec 31, 2015
10-Q Quarterly report Nov 6, 2015 Sep 30, 2015
10-Q Quarterly report May 19, 2015 Mar 31, 2015
10-Q Quarterly report Apr 15, 2015 Feb 28, 2015
10-Q Quarterly report Jan 12, 2015 Nov 30, 2014
10-Q Quarterly report Jul 10, 2014 May 31, 2014
10-Q Quarterly report Apr 11, 2014 Feb 28, 2014
10-Q Quarterly report Jan 10, 2014 Nov 30, 2013
10-Q Quarterly report Jun 28, 2013 May 31, 2013
10-Q Quarterly report Apr 15, 2013 Feb 28, 2013
10-Q Quarterly report Jan 14, 2013 Nov 30, 2012
10-Q Quarterly report Jun 26, 2012 May 31, 2012
10-Q Quarterly report Apr 12, 2012 Feb 29, 2012
10-Q Quarterly report Dec 23, 2011 Nov 30, 2011
10-Q Quarterly report Jul 13, 2011 May 31, 2011
10-Q Quarterly report Apr 14, 2011 Feb 28, 2011
10-Q Quarterly report Jan 13, 2011 Nov 30, 2010
10-Q Quarterly report Jul 15, 2010 May 31, 2010
10-Q Quarterly report Apr 14, 2010 Dec 31, 2009
10-Q Quarterly report Jan 14, 2010 Nov 30, 2009
10-Q Quarterly report Jul 13, 2009 May 31, 2009
10-Q Quarterly report Apr 13, 2009 Feb 28, 2009
10-Q Quarterly report Dec 15, 2008 Nov 30, 2008

Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AYTU (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Denver, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1385818
Former names
AYTU BIOSCIENCE, INC (until Mar 22, 2021); Rosewind CORP (until Jun 8, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.